Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NB01 in moderate acne
NCT03450369Phase 1Completed
- Sponsor
- Naked Biome
- Start
- Jan 2018
- Primary completion
- Jun 2018
- Modality
- Small Molecules, Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of DA-9801 in acne vulgaris, sponsored by Naked Biome. Primary endpoints: Successful Engraftment of Probiotic at 2 months, Dose Schedule Determination at 48 hours and 9 more. Started Jan 2018; status: completed.
02
Drugs
DA-9801
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT03450369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03450369.